On Invalid Date, Argenx Se (NASDAQ: ARGX) reported Q4 2022 earnings per share (EPS) of N/A, up N/A year over year. Total Argenx Se earnings for the quarter were N/A. In the same quarter last year, Argenx Se's earnings per share (EPS) was N/A.
As of Q1 2023, Argenx Se's earnings has grown year over year. Argenx Se's earnings in the past year totalled -$754.89 million.
What is ARGX's earnings date?
Argenx Se's earnings date is Invalid Date. Add ARGX to your watchlist to be reminded of ARGX's next earnings announcement.
What was ARGX's revenue last quarter?
On Invalid Date, Argenx Se (NASDAQ: ARGX) reported Q4 2022 revenue of N/A up N/A year over year. In the same quarter last year, Argenx Se's revenue was N/A.
What was ARGX's revenue growth in the past year?
As of Q1 2023, Argenx Se's revenue has grown -98.11% year over year. This is 159.67 percentage points lower than the US Biotechnology industry revenue growth rate of 61.56%. Argenx Se's revenue in the past year totalled $10.67 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.